
Ascendis Pharma A/S ASND
$ 208.71
-1.93%
Annual report 2024
added 12-06-2025
Ascendis Pharma A/S DSO Ratio 2011-2025 | ASND
Annual DSO Ratio Ascendis Pharma A/S
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 132 | 98.3 | 62 | - | - | - |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 132 | 62 | 97.5 |
DSO Ratio of other stocks in the Biotechnology industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Arbutus Biopharma Corporation
ABUS
|
31.5 | $ 4.77 | -0.42 % | $ 792 M | ||
|
Aclaris Therapeutics
ACRS
|
6.01 | $ 3.04 | -0.01 % | $ 235 M | ||
|
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 | - | - | $ 40.3 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
28.1 | $ 0.23 | 25.51 % | $ 500 M | ||
|
Aptorum Group Limited
APM
|
20.6 | $ 1.17 | - | $ 6.38 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
204 | - | -18.52 % | $ 27.3 M | ||
|
Celldex Therapeutics
CLDX
|
86.5 | $ 26.25 | -2.18 % | $ 1.69 M | ||
|
Aptevo Therapeutics
APVO
|
79 | $ 0.58 | -37.19 % | $ 160 K | ||
|
Alterity Therapeutics Limited
ATHE
|
16.2 K | $ 3.16 | 2.1 % | $ 7.6 B | ||
|
Athersys
ATHX
|
22.6 | - | 3.77 % | $ 22.4 M | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
25 | - | -15.15 % | $ 60.3 M | ||
|
BioDelivery Sciences International
BDSI
|
115 | - | -4.8 % | $ 255 M | ||
|
Albireo Pharma
ALBO
|
14.7 | - | -0.23 % | $ 916 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
62.6 | $ 26.85 | 0.13 % | $ 1.3 B | ||
|
Dynavax Technologies Corporation
DVAX
|
56.5 | $ 15.39 | 0.03 % | $ 2 B | ||
|
BeiGene, Ltd.
BGNE
|
49.5 | - | 0.49 % | $ 251 B | ||
|
Anika Therapeutics
ANIK
|
77.3 | $ 9.51 | 0.32 % | $ 139 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
6.09 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
103 | - | -7.31 % | $ 87 M | ||
|
bluebird bio
BLUE
|
2.47 | - | - | $ 546 M | ||
|
Arena Pharmaceuticals
ARNA
|
946 | - | -6.81 % | $ 3.04 B | ||
|
Eton Pharmaceuticals
ETON
|
30.4 | $ 16.94 | -0.29 % | $ 434 M | ||
|
Evogene Ltd.
EVGN
|
30 | $ 1.01 | -3.33 % | $ 27.9 M | ||
|
Calithera Biosciences
CALA
|
28.8 | - | -10.95 % | $ 876 K | ||
|
Axon Enterprise
AXON
|
134 | $ 585.85 | -0.9 % | $ 44.4 B | ||
|
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M | ||
|
Exelixis
EXEL
|
45.1 | $ 46.2 | -0.68 % | $ 13.4 B | ||
|
Aytu BioScience
AYTU
|
150 | $ 2.49 | -1.58 % | $ 15.6 M | ||
|
Acorda Therapeutics
ACOR
|
48.3 | - | -24.86 % | $ 820 K | ||
|
Catalyst Biosciences
CBIO
|
3.24 | $ 12.47 | 0.81 % | $ 821 M |